Correlation between clonal hematopoiesis and peri-operative severe complications in esophageal cancer patients

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100044175

Enrollment

Unknown

Registered

2021-03-12

Start date

2021-04-01

Completion date

Unknown

Last updated

2022-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal cancer

Interventions

Clonal Hematopoiesis group:N/A

non-Clonal Hematopoiesis group:N/A

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with esophageal malignancy; 2. Patients undergoing radical esophagectomy in our hospital; 3. Adult patients older than 18 years old.

Exclusion criteria

Exclusion criteria: 1. Patients who have not undergone radical esophagectomy due to various reasons; 2. Patients with a history of hematological tumors or current hematological tumors; 3. Patients who have had bone marrow transplantation or hematopoietic stem cell transplantation in the past.

Design outcomes

Primary

Measure	Time frame
Clonal hematopoiesis;Perioperative severe complications;Survival time;	—

Countries

China

Contacts

Public ContactWang Hao

Zhongshan Hospital, Fudan University

wang.hao2@zs-hospital.sh.cn+86 13501622126

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 9, 2026